Indian Company Master Data Made Simple
Ishita Drugs And Industries Limited
Established in 1992, Ishita Drugs And Industries Limited has 33 years of operational experience. Its CIN is L24231GJ1992PLC017054, with registration number 17054. It falls under the category of company limited by shares. Authorized share capital stands at ₹6.00 crore. Paid-up capital for the company equals ₹2.99 crore.
The company specializes in manufacture of chemicals and chemical products operations. It is registered in Ahmedabad. Its registered address is Survey No 179/1, Vasna-iyava, Taluka Sanand, Ahmedabad, Gujarat, India, 382210. It is officially listed as an active business entity. The company may be contacted through its official email: [email protected]. The leadership team includes Sumit Jagdishprasad Agrawal (CFO).
Profile data last updated: 19/09/2025
Company Overview
- CIN
- Date of Incorporation
- 05/02/1992
- Company Status
- Active
- RoC
- Ahmedabad
- Registration Number
- Balance sheet date
- 2024-03-31
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹6,00,00,000.00
- Paid up Capital
- ₹2,99,03,000.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | ₹10.14L | ₹1.99L | ₹2.11L | ₹2.91L | ₹0.00L |
| Accumulated Depreciation | -₹396.01L | -₹395.36L | -₹384.19L | -₹371.27L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹550.62L | ₹88.71L | ₹223.41L | ₹265.83L | ₹0.00L |
| Tangible Book Value | ₹1,078.96L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Long Term Debt | ₹8.94L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹381.35L | ₹0.00L | ₹96.04L | ₹0.00L | ₹0.00L |
| Machinery Furniture Equipment | ₹381.18L | ₹373.08L | ₹357.46L | ₹356.99L | ₹0.00L |
| Total Assets | ₹1,629.58L | ₹1,080.87L | ₹1,140.72L | ₹1,125.40L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,078.96L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Gross PPE | ₹483.91L | ₹475.82L | ₹473.14L | ₹459.72L | ₹0.00L |
| Total Capitalization | ₹1,087.91L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Common Stock | ₹299.03L | ₹299.03L | ₹299.03L | ₹299.03L | ₹0.00L |
| Total Debt | ₹390.30L | ₹0.00L | ₹96.04L | ₹0.00L | ₹0.00L |
| Other Equity Interest | ₹1.65L | ₹1.65L | ₹1.65L | ₹1.65L | ₹0.00L |
| Other Non Current Liabilities | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Capital Stock | ₹299.03L | ₹299.03L | ₹299.03L | ₹299.03L | ₹0.00L |
| Total Non Current Assets | ₹131.24L | ₹115.17L | ₹122.96L | ₹120.67L | ₹0.00L |
| Invested Capital | ₹1,469.26L | ₹992.15L | ₹1,013.35L | ₹859.56L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹834.89L | ₹787.49L | ₹655.09L | ₹847.51L | ₹0.00L |
| Net Tangible Assets | ₹1,078.96L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Cash And Cash Equivalents | ₹56.84L | ₹182.53L | ₹60.55L | ₹198.68L | ₹0.00L |
| Prepaid Assets | ₹3.24L | ₹1.77L | ₹2.56L | ₹2.28L | ₹0.00L |
| Stockholders Equity | ₹1,078.96L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Other Short Term Investments | ₹778.05L | ₹604.96L | ₹594.54L | ₹648.84L | ₹0.00L |
| Share Issued | ₹29.90L | ₹29.90L | ₹29.90L | ₹29.90L | ₹0.00L |
| Current Assets | ₹1,498.35L | ₹965.70L | ₹1,017.76L | ₹1,004.72L | ₹0.00L |
| Working Capital | ₹957.87L | ₹878.98L | ₹796.46L | ₹741.80L | ₹0.00L |
| Net Debt | ₹333.46L | ₹0.00L | ₹35.49L | ₹0.00L | ₹0.00L |
| Current Debt | ₹381.35L | ₹0.00L | ₹96.04L | ₹0.00L | ₹0.00L |
| Ordinary Shares Number | ₹29.90L | ₹29.90L | ₹29.90L | ₹29.90L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹8.94L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Liabilities | ₹540.48L | ₹86.73L | ₹221.30L | ₹262.92L | ₹0.00L |
| Net PPE | ₹87.90L | ₹80.46L | ₹88.95L | ₹88.46L | ₹0.00L |
| Common Stock Equity | ₹1,078.96L | ₹992.15L | ₹917.30L | ₹859.56L | ₹0.00L |
| Other Non Current Assets | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L | -₹0.00L |
| Other Properties | ₹21.99L | ₹21.99L | ₹34.94L | ₹21.99L | ₹0.00L |
| Inventory | ₹446.49L | ₹106.42L | ₹159.83L | ₹97.37L | ₹0.00L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹2.40L | ₹138.15L | -₹125.36L | ₹214.36L | ₹0.00L |
| Financing Cash Flow | ₹432.74L | -₹86.95L | ₹104.97L | ₹0.17L | ₹0.00L |
| Free Cash Flow | -₹382.14L | ₹209.40L | -₹303.16L | ₹305.78L | ₹0.00L |
| Investing Cash Flow | -₹66.63L | ₹13.03L | ₹59.42L | -₹93.44L | ₹0.00L |
| End Cash Position | ₹483.38L | ₹480.98L | ₹342.83L | ₹468.19L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L |
| Capital Expenditure | -₹18.42L | -₹2.68L | -₹13.42L | -₹1.85L | ₹0.00L |
| Beginning Cash Position | ₹480.98L | ₹342.83L | ₹468.19L | ₹253.83L | ₹0.00L |
| Operating Cash Flow | -₹363.71L | ₹212.08L | -₹289.75L | ₹307.63L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|
| Rent Expense Supplemental | ₹20.89L | ₹23.62L | ₹30.38L | ₹19.95L |
| Net Income From Continuing Operation Net Minority Interest | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Net Income Discontinuous Operations | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹129.96L | ₹116.12L | ₹94.52L | ₹117.70L |
| Total Expenses | ₹1,410.56L | ₹1,439.08L | ₹1,143.99L | ₹1,312.91L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Revenue | ₹1,499.73L | ₹1,518.76L | ₹1,207.23L | ₹1,409.05L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Income Non Operating | ₹28.46L | ₹18.06L | ₹14.28L | ₹6.82L |
| Interest Expense Non Operating | ₹3.46L | ₹6.23L | ₹3.65L | ₹0.43L |
| Interest Income | ₹28.46L | ₹18.06L | ₹14.28L | ₹6.82L |
| Net Income From Continuing And Discontinued Operation | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| General And Administrative Expense | ₹58.67L | ₹45.59L | ₹36.01L | ₹49.60L |
| Reconciled Depreciation | ₹10.98L | ₹11.17L | ₹12.93L | ₹12.98L |
| Net Income Continuous Operations | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Reconciled Cost Of Revenue | ₹1,127.53L | ₹1,171.22L | ₹899.84L | ₹1,071.50L |
| Operating Income | ₹89.16L | ₹79.68L | ₹63.25L | ₹96.14L |
| Net Income | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Diluted Average Shares | ₹29.90L | ₹29.90L | ₹29.90L | ₹29.90L |
| Selling And Marketing Expense | ₹48.82L | ₹45.27L | ₹28.90L | ₹30.47L |
| Normalized Income | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Total Other Finance Cost | ₹3.76L | ₹2.75L | ₹1.71L | ₹2.03L |
| Net Non Operating Interest Income Expense | ₹21.24L | ₹9.09L | ₹8.93L | ₹4.36L |
| Gross Profit | ₹372.19L | ₹347.54L | ₹307.39L | ₹337.55L |
| EBIT | ₹118.98L | ₹104.95L | ₹81.59L | ₹104.73L |
| Cost Of Revenue | ₹1,127.53L | ₹1,171.22L | ₹899.84L | ₹1,071.50L |
| Diluted NIAvailto Com Stockholders | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Net Interest Income | ₹21.24L | ₹9.09L | ₹8.93L | ₹4.36L |
| Normalized EBITDA | ₹129.96L | ₹116.12L | ₹94.52L | ₹117.70L |
| Operating Expense | ₹283.03L | ₹267.86L | ₹244.15L | ₹241.41L |
| Net Income Common Stockholders | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Pretax Income | ₹115.51L | ₹98.73L | ₹77.94L | ₹104.30L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹1,499.73L | ₹1,518.76L | ₹1,207.23L | ₹1,409.05L |
| Selling General And Administration | ₹107.49L | ₹90.86L | ₹64.91L | ₹80.08L |
| Other Operating Expenses | ₹9.24L | ₹8.31L | ₹7.57L | ₹10.32L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense | ₹3.46L | ₹6.23L | ₹3.65L | ₹0.43L |
| Basic Average Shares | ₹29.90L | ₹29.90L | ₹29.90L | ₹29.90L |
| Net Income Extraordinary | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Provision | ₹28.71L | ₹23.88L | ₹20.20L | ₹23.80L |
| Net Income Including Noncontrolling Interests | ₹86.81L | ₹74.85L | ₹57.74L | ₹80.50L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 05/02/1992 | Jagdishprasad Agrawal Gokulchand | 01031687 | Managing Director | View other directorships |
| 05/02/1992 | Abha Agrawal Jagdishprasad | 01589479 | Director | View other directorships |
| 13/11/2018 | Sumit Jagdishprasad Agrawal | *****7406J | CFO | |
| 12/11/2019 | Arvind Vilasrao Sapkal | 08607096 | Director | View other directorships |
| 04/02/2021 | Srushti Pandya | *****5733H | Company Secretary | |
| 13/08/2024 | Dhwani Jaspalsinh Solanki | 10299290 | Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 21/11/2024 | Form MGT-7-21112024 | - |
| 12/11/2024 | Form AOC-4(XBRL)-28102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Denis Chem Lab Limited | L24230GJ1980PLC003843 | Block No 457chhatral, Kalol, Gujarat, India, 382729 |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Survey No 179/1, Vasna-iyava, Taluka Sanand, Ahmedabad, Gujarat, India, 382210
FAQ
What is the incorporation date of Ishita Drugs And Industries Limited?
The incorporation date of Ishita Drugs And Industries Limited is 05/02/1992.
Who are the current board members & directors of Ishita Drugs And Industries Limited?
The current board member of Ishita Drugs And Industries Limited are:
- Jagdishprasad Agrawal Gokulchand
- Abha Agrawal Jagdishprasad
- Arvind Vilasrao Sapkal
- Dhwani Jaspalsinh Solanki
What is the registered address of Ishita Drugs And Industries Limited?
The registered address of Ishita Drugs And Industries Limited is Survey No 179/1, Vasna-iyava, Taluka Sanand, Ahmedabad, Gujarat, India, 382210.
What is the Corporate Identification Number of Ishita Drugs And Industries Limited?
The Corporate Identification Number of Ishita Drugs And Industries Limited is L24231GJ1992PLC017054.